New Zealand markets close in 2 hours 10 minutes

PT Kalbe Farma Tbk. (KLBF.JK)

Jakarta - Jakarta Delayed price. Currency in IDR
Add to watchlist
1,755.00-50.00 (-2.77%)
At close: 04:11PM WIB
Currency in IDR

Valuation measures4

Market cap (intra-day) 81.18T
Enterprise value 80.13T
Trailing P/E 24.90
Forward P/E 22.47
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.70
Price/book (mrq)4.04
Enterprise value/revenue 2.65
Enterprise value/EBITDA 17.20

Trading information

Stock price history

Beta (5Y monthly) 0.23
52-week change 3-4.10%
S&P500 52-week change 319.21%
52-week high 32,360.00
52-week low 30.00
50-day moving average 31,836.40
200-day moving average 32,033.03

Share statistics

Avg vol (3-month) 338.58M
Avg vol (10-day) 331.1M
Shares outstanding 546.26B
Implied shares outstanding 646.26B
Float 818.96B
% held by insiders 158.23%
% held by institutions 114.99%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 438
Forward annual dividend yield 42.17%
Trailing annual dividend rate 338.00
Trailing annual dividend yield 32.11%
5-year average dividend yield 41.83
Payout ratio 453.92%
Dividend date 3N/A
Ex-dividend date 412 May 2023
Last split factor 25:1
Last split date 308 Oct 2012

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 10.83%
Operating margin (ttm)13.84%

Management effectiveness

Return on assets (ttm)9.93%
Return on equity (ttm)15.50%

Income statement

Revenue (ttm)30.24T
Revenue per share (ttm)650.81
Quarterly revenue growth (yoy)6.60%
Gross profit (ttm)11.52T
EBITDA 4.85T
Net income avi to common (ttm)3.27T
Diluted EPS (ttm)70.55
Quarterly earnings growth (yoy)-16.10%

Balance sheet

Total cash (mrq)2.89T
Total cash per share (mrq)62.48
Total debt (mrq)1.85T
Total debt/equity (mrq)8.48%
Current ratio (mrq)3.35
Book value per share (mrq)434.74

Cash flow statement

Operating cash flow (ttm)1.47T
Levered free cash flow (ttm)-671.17B